Limitations of Metabolic Activation Systems Used with in Vitro Tests for Carcinogens

Abstract

Important differences between the metabolic activation of 7,12-dimethylbenz[a]anthracene in intact cellular systems and in liver homogenates suggest that the use of homogenates in conjunction with short-term assays for carcinogens could yield misleading results.